13 Best Multibagger Stocks to Invest in Now
The global economic and geopolitical environment in 2025 is marked by uncertainty, trade tensions, and shifting monetary policies.
Aquestive Therapeutics Inc. (AQST)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Perceptive Advisors Joseph Edelman | 3,727,208 | $10,808,903 | 0.38% | |
| 2. | Pale Fire Capital Dusan Senkypl, David Holy, And Jan Barta | 1,335,684 | $3,873,484 | +155% | 0.46% |
| 3. | Stonepine Capital Timothy P. Lynch | 200,000 | $3,039,973 | +25% | 2.96% |
| 4. | Two Sigma Advisors John Overdeck And David Siegel | 576,400 | $1,671,560 | +3503% | 0% |
| 5. | Citadel Investment Group Ken Griffin | 459,550 | $1,332,695 | +21% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $0.81 | 5,000 | $4,050.00 | 59,532 | 2022-06-14 | Filing | |
| $0.96 | 91,743 | $88,073.28 | 193,702 | 2022-06-08 | Filing | |
| $0.96 | 45,871 | $44,036.16 | 882,871 | 2022-06-08 | Filing | |
| $0.96 | 2,293 | $2,201.28 | 54,532 | 2022-06-08 | Filing | |
| $0.96 | 13,761 | $13,210.56 | 38,761 | 2022-06-08 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $4.87 | 44 | $214.06 | 0 | 2024-11-26 | Filing | |
| $6.00 | 50,000 | $300,000.00 | 984,476 | 2024-03-15 | Filing | |
| $5.19 | 25,000 | $129,685.00 | 1,040,371 | 2024-03-08 | Filing | |
| $6.75 | 23,460 | $158,355.00 | 837,000 | 2021-02-10 | Filing | |
| $6.75 | 11,540 | $77,895.00 | 860,460 | 2021-02-09 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 9,810,958 | $28,451,778 | 100% | |
| 2. | 5,935,754 | $17,213,686 | 0% | |
| 3. | 4,073,558 | $11,813,318 | 0% | |
| 4. | 1,700,706 | $4,933,107 | 0% | |
| 5. | 1,527,289 | $4,429,139 | 0% |
News See All
Aquestive Therapeutics, Inc. (NASDAQ:AQST) Q1 2025 Earnings Call Transcript
Operator: Good day and thank you for standing by. Welcome to the Aquestive Therapeutics First Quarter 2025 Earnings Conference Call. At this time, all participants are in a listen-only mode.
Aquestive Therapeutics, Inc. (NASDAQ:AQST) Q4 2024 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to the Fourth Quarter 2024 Aquestive Therapeutics Earnings Conference Call. At this time, all participants are in a listen-only mode.
10 Best Multibagger Stocks To Buy Heading into 2025
November has been an eventful month so far for the market as the Fed cut rates by a quarter percentage and president-elect, Donald Trump won the election for the second time.
Aquestive Therapeutics, Inc. (NASDAQ:AQST) Q3 2024 Earnings Call Transcript
Operator: Good morning, and welcome to the Aquestive Therapeutics Third Quarter 2024 Conference Call. At this time, all participants are in a listen-only mode.
Aquestive Therapeutics, Inc. (NASDAQ:AQST) Q2 2024 Earnings Call Transcript
Operator: Good morning, and welcome to the Aquestive Therapeutics Second Quarter 2024 Conference Call. [Operator Instructions] As a reminder, this call will be recorded.
Aquestive Therapeutics, Inc. (NASDAQ:AQST) Q1 2024 Earnings Call Transcript
Operator: Good morning, and welcome to Aquestive Therapeutics First Quarter 2024 Conference Call. At this time, all participants are in a listen-only mode.
Aquestive Therapeutics, Inc. (NASDAQ:AQST) Q4 2023 Earnings Call Transcript
Operator: Good morning, and welcome to Aquestive Therapeutics Fourth Quarter and Full Year 2023 Conference Call. At this time, all participants are in a listen-only mode.
Aquestive Therapeutics, Inc. (NASDAQ:AQST) Q3 2023 Earnings Call Transcript
Operator: Good morning and welcome to the Aquestive Therapeutics Third Quarter 2023 Conference Call. At this time, all participants are in a listen-only mode.
Aquestive Therapeutics, Inc. (NASDAQ:AQST) Q2 2023 Earnings Call Transcript
Operator: Good morning and welcome to the Aquestive Therapeutics Second Quarter 2023 Conference Call. At this time, all participants are in a listen-only mode.
Billionaire Hedge Funds
